Pictured: 2012 Rock Stars of Science
Announcement
By Allyson Collins, MS, Science Writer/Editor  |  Thursday, December 6, 2012

The initiative, focused on investigators from Memorial Sloan Kettering’s Geoffrey Beene Cancer Research Center, highlights the critical need for funding scientific research.

Pictured: Clifford Hudis
Q&A
By Esther Napolitano, BS, Science Writer/Editor  |  Wednesday, December 5, 2012

New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.

Feature
By Memorial Sloan Kettering  |  Monday, December 3, 2012

Memorial Sloan Kettering physicians and nurses take their knowledge and expertise overseas.

Pictured: Michael Zelefsky
In the Clinic
By Andrea Peirce, BA and Media Staff
Friday, November 30, 2012

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Pictured: Carol Brown
Video
By Memorial Sloan Kettering  |  Wednesday, November 28, 2012

Gynecologic cancer surgeon Dr. Brown discusses how doctors and nurses collaborate to care for patients, from diagnosis through lifelong follow-up.

Pictured: Michael Berger & David Solit
Feature
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, November 26, 2012

At Memorial Sloan Kettering, new technologies to study gene changes in cancer cells are accelerating the development and implementation of more-effective treatments.

Q&A
By Media Staff  |  Wednesday, November 21, 2012

Cancer patients use more blood and platelets than patients with any other illness. Memorial Sloan Kettering is always in need of blood donations – especially during the holiday season.

Pictured: Scott Lowe
Q&A
By Eva Kiesler, PhD, Science Writer/Editor  |  Monday, November 19, 2012

In the lab of cancer biologist Scott Lowe, researchers are investigating the processes that naturally inhibit cancer development.

In the News
By Julie Grisham, MS, Science Writer/Editor  |  Friday, November 16, 2012

Memorial Sloan Kettering has been praised for taking a stand on the price for a new cancer drug that costs more than twice as much as another, similar drug.

Pictured: PET Scan
In the Lab
By Eva Kiesler, PhD, Science Writer/Editor  |  Thursday, November 15, 2012

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

Pictured: Jatin Shah
Video
By Memorial Sloan Kettering  |  Monday, November 12, 2012

Dr. Shah, Chief of the Head and Neck Service, discusses how Memorial Sloan Kettering’s world-renowned head and neck surgeons partner with patients to select the most appropriate treatment plan.

Pictured: Marc Ladanyi & Snjezana Dogan
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Friday, November 9, 2012

A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.

Pictured: Martin Weiser
In the Clinic
By Jim Stallard, MA, Writer/Editor  |  Thursday, November 8, 2012

Memorial Sloan Kettering’s colorectal cancer team has developed online prediction tools that assess disease risk following surgery, enabling patients and physicians to make better treatment decisions.

Event
By Andrea Peirce, BA, Writer/Editor  |  Tuesday, November 6, 2012

For the first time, our annual seminar for high school students and teachers from the New York City area will be available to watch live from around the nation and the world.

Pictured: Ping Chi
Q&A
By Julie Grisham, MS, Science Writer/Editor  |  Friday, November 2, 2012

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Center News

Stay Informed

Get the latest information about cancer care and research every month.